OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting-Reference-Cited by-同舟云学术

OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting

Published:2024-05 Issue:5 Volume:14 Page:1273-1291
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Alulis Sarah,Bernardini Nicoletta,Burlando Martina,Costanzo Antonio,Francesa Morel Pier Cesare^ORCID,Gisondi Paolo,Loconsole Francesco,Megna Matteo,Pellacani Giovanni,Piaserico Stefano,Prignano Francesca,Secchi Ottavio,Skroza Nevena,Hassan Fareen

Funder

Janssen-Cilag Ltd

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13555-024-01170-8.pdf

Reference51 articles.

1. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) Project Team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013;133:377–85.

2. Ministero della Salute. Linea guida sulla psoriasi, presentato aggiornamento coordinato dall’ISS. 2013. https://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=null&id=1072. Accessed 2 Feb 2023.

3. Bardazzi F, Bonci C, Sacchelli L, et al. Suicide risk and depression in patients with psoriasis. Ital J Dermatol Venerol. 2022;157:497–501.

4. Armstrong AW, Puig L, Joshi A, et al. Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis. JAMA Dermatol. 2020;156:258–69.

5. Hart RJ, Hassan F, Alulis S, et al. Modelling treatment sequences in immunology: optimizing patient outcomes. Adv Ther. 2024. https://doi.org/10.1007/s12325-023-02766-w